Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney Disease
Clinical trial NCT04595370 · COMPLETED
Trial details
- NCT number
- NCT04595370
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-26
- Primary completion
- 2023-09-22
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.